| Assessment of the cPAS-based BGISEQ-500 platform for metagenomic sequencing C Fang, H Zhong, Y Lin, B Chen, M Han, H Ren, H Lu, JM Luber, M Xia, ... Gigascience 7 (3), gix133, 2018 | 166 | 2018 |
| Impact of HER2 heterogeneity on treatment response of early-stage HER2-positive breast cancer: phase II neoadjuvant clinical trial of T-DM1 combined with pertuzumab O Metzger Filho, G Viale, S Stein, L Trippa, DA Yardley, IA Mayer, ... Cancer discovery 11 (10), 2474-2487, 2021 | 116 | 2021 |
| Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients S Stein, R Zhao, H Haeno, I Vivanco, F Michor PLoS Computational Biology 14 (1), e1005924, 2018 | 39 | 2018 |
| The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer M Janiszewska, S Stein, O Metzger Filho, J Eng, NL Kingston, NW Harper, ... JCI insight 6 (11), 2021 | 35 | 2021 |
| Detecting allele-specific alternative splicing from population-scale RNA-Seq data L Demirdjian, Y Xu, E Bahrami-Samani, Y Pan, S Stein, Z Xie, E Park, ... The American Journal of Human Genetics 107 (3), 461-472, 2020 | 17 | 2020 |
| Discover hidden splicing variations by mapping personal transcriptomes to personal genomes S Stein, Z Lu, E Bahrami-Samani, JW Park, Y Xing Nucleic acids research 43 (22), 10612-10622, 2015 | 16 | 2015 |
| Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies KN Yamamoto, A Nakamura, LL Liu, S Stein, AC Tramontano, U Kartoun, ... PloS one 14 (4), e0215409, 2019 | 8 | 2019 |
| Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast Cancer YC Cheng, S Stein, A Nardone, W Liu, W Ma, G Cohen, C Guarducci, ... Cancer Research Communications 3 (11), 2331-2344, 2023 | 2 | 2023 |
| Using RNA-Seq to Discover genetic polymorphisms that produce hidden splice variants S Stein, E Bahrami-Samani, Y Xing mRNA Processing: Methods and Protocols, 129-142, 2017 | 2 | 2017 |
| Mathematical Modeling of Tumor Evolution and Response to Therapy S Stein Harvard University, 2021 | | 2021 |
| Abstract B16: Mathematical modeling identifies optimum palbociclib dosing schedules for the treatment of estrogen receptor-positive (ER+) breast cancer patients S Stein, A Nardone, W Liu, G Cohen, C Guarducci, M Brown, R Jeselsohn, ... Cancer Research 80 (11_Supplement), B16-B16, 2020 | | 2020 |
